Wendy L Yarno is Director of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 10,350 shares of TARS, which is worth approximately $569,250. The most recent transaction as insider was on Jun 24, 2024, when has been sold 3,350 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.4K
0% 3M change
47.86% 12M change
Total Value Held $569,250

WENDY L YARNO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
BUY
Exercise of conversion of derivative security
-
3,350 Added 24.45%
10,350 Common Stock
Dec 02 2023
BUY
Exercise of conversion of derivative security
-
5,000 Added 41.67%
7,000 Common Stock
Jun 16 2023
BUY
Exercise of conversion of derivative security
-
2,000 Added 50.0%
2,000 Common Stock

Also insider at

GBT
Global Blood Therapeutics, Inc. Healthcare
IOVA
IOVANCE BIOTHERAPEUTICS, INC. Healthcare
IDYA
IDEAYA Biosciences, Inc. Healthcare
INO
INOVIO PHARMACEUTICALS, INC. Healthcare
MYOK
MyoKardia Inc
WLY

Wendy L Yarno

Director
South San Francisco, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS